Document is current
Any future updates will be listed below
-
Authors
Stabile, Cara
McCready, Taylor
Ancker, Jessica S.
Pusic, Andrea
Temple, Larissa K. F.
Vickers, Andrew
Simon, Brett
Ashby, Christina
Carter, Jeanne
- License Information
-
More Information
Article History
Received: 10 August 2021
Accepted: 15 March 2022
First Online: 23 March 2022
Declarations
:
: The “ACCESS” study was approved by the Institutional Review Board at MSK (as a low-risk protocol, with waiver of written consent. This was a low-risk protocol, with waiver of written consent by MSK.
: Not applicable.
: <b>AP</b> is co-developer of QPROMS, which are owned by Memorial Sloan Kettering Cancer Center. She receives royalty payments when QPROMS are used in industry-sponsored clinical trials. The other authors have no conflicts of interest to declare that are relevant to the content of this article.
